Neuronal recordings in Parkinson's disease Patients with dyskinesias induced by apomorphine

被引:0
|
作者
Lozano, AM
Lang, AE
Levy, R
Hutchison, W
Dostrovsky, J
机构
[1] Univ Toronto, Toronto Hosp, Div Neurosurg, Dept Surg,Western Div, Toronto, ON M5T 2S8, Canada
[2] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada
[3] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dopaminergic agents reverse parkinsonism but commonly induce dyskinesia in patients with Parkinson's disease (PD) on long-term levodopa therapy. The aim of this study was to determine the neurophysiologic correlates of the amelioration of parkinsonism and the involuntary movements produced by the dopamine agonist apomorphine. Seventeen PD patients were given apomorphine (2-6 mg) before surgery. Neural activity was recorded for individual neurons and for populations of neurons before and after apomorphine. Both internal (GPI) and external (GPe) segments of the globus pallidus were sampled in patients undergoing pallidal surgery. The subthalamic nucleus (STN) was sampled in STN surgery patients. Results suggest that dopaminergic agents act by decreasing GPi and STN activity, and increasing GPe activity, and that drug-induced dyskinesias results from a large reduction in GPi firing.
引用
收藏
页码:S141 / S146
页数:6
相关论文
共 50 条
  • [41] Pathophysiological basis of drug-induced dyskinesias in Parkinson's disease
    Deogaonkar, M
    Subramanian, T
    BRAIN RESEARCH REVIEWS, 2005, 50 (01) : 156 - 168
  • [42] Risk factors for levodopa-induced dyskinesias in Parkinson's disease
    Grandas, F
    Galiano, ML
    Tabernero, C
    JOURNAL OF NEUROLOGY, 1999, 246 (12) : 1127 - 1133
  • [43] Levodopa-induced dyskinesias in Parkinson's disease: emerging treatments
    Bargiotas, Panagiotis
    Konitsiotis, Spyridon
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1605 - 1617
  • [44] Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease
    Baron, MS
    Dalton, WB
    MOVEMENT DISORDERS, 2003, 18 (10) : 1208 - 1209
  • [45] Suppression of L-DOPA induced dyskinesias in advanced Parkinson's disease by continuous subcutaneous infusions of apomorphine - ten years of experience
    Kanovsky, P.
    Bares, M.
    Rektorova, I.
    Kubova, D.
    Nestrasil, I.
    Farnikova, K.
    Ressner, P.
    Rektor, I.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S119 - S120
  • [46] Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease
    Metman, LV
    Del Dotto, P
    Natté, R
    van den Munckhof, P
    Chase, TN
    NEUROLOGY, 1998, 51 (01) : 203 - 206
  • [47] Levetiracetam for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
    Stathis, P.
    Konitsiotis, S.
    Tagaris, G.
    Peterson, D.
    MOVEMENT DISORDERS, 2011, 26 (02) : 264 - 270
  • [48] Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease
    Hoff, JI
    vander Plas, AA
    Wagemans, EAH
    van Hilten, JJ
    MOVEMENT DISORDERS, 2001, 16 (01) : 58 - 61
  • [49] Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease
    Merims, D
    Ziv, I
    Djaldetti, R
    Melamed, E
    LANCET, 1999, 353 (9166): : 1764 - 1765
  • [50] The effect of subthalamic nucleus stimulation on levodopa-induced dyskinesias in patients with Parkinson's disease
    Fraix, V
    Pollak, P
    Van Blercom, N
    Xie, J
    Krack, P
    Benabid, AL
    NEUROLOGY, 1999, 52 (06) : A403 - A404